Cargando…

Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging

Erdheim–Chester disease is a rare disease with systemic non-Langerhans cell histiocytosis, the diagnosis of which with conventional imaging modalities is challenging. We describe a case of a 73-year-old woman who was referred with a progressive history of bilateral proptosis. The magnetic resonance...

Descripción completa

Detalles Bibliográficos
Autores principales: Jois, Bhargavi, Ananthasivan, Rupa, Rawat, Parameswaran R. V. Sudarshan, Rakshit, Susmita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590557/
https://www.ncbi.nlm.nih.gov/pubmed/34790325
http://dx.doi.org/10.1055/s-0041-1736164
_version_ 1784598999808868352
author Jois, Bhargavi
Ananthasivan, Rupa
Rawat, Parameswaran R. V. Sudarshan
Rakshit, Susmita
author_facet Jois, Bhargavi
Ananthasivan, Rupa
Rawat, Parameswaran R. V. Sudarshan
Rakshit, Susmita
author_sort Jois, Bhargavi
collection PubMed
description Erdheim–Chester disease is a rare disease with systemic non-Langerhans cell histiocytosis, the diagnosis of which with conventional imaging modalities is challenging. We describe a case of a 73-year-old woman who was referred with a progressive history of bilateral proptosis. The magnetic resonance imaging (MRI) orbit demonstrated bilateral orbital masses with optic nerve encasement. A subsequent 18F-FDG PET/CT scan showed multi-organ disease with involvement of the orbits, pericardium, aorta, pararenal fascia, and appendicular bones. Metabolically active, easily accessible areas were selected for CT-guided biopsy. The biopsy showed sheets of foamy histiocytes with the expression of CD 68 and CD 163 consistent with a diagnosis of Erdheim–Chester disease. The FDG PET/CT played a pivotal role in establishing the diagnosis with the assessment of disease extent and further guided in the targeted biopsy.
format Online
Article
Text
id pubmed-8590557
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-85905572021-11-16 Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging Jois, Bhargavi Ananthasivan, Rupa Rawat, Parameswaran R. V. Sudarshan Rakshit, Susmita Indian J Radiol Imaging Erdheim–Chester disease is a rare disease with systemic non-Langerhans cell histiocytosis, the diagnosis of which with conventional imaging modalities is challenging. We describe a case of a 73-year-old woman who was referred with a progressive history of bilateral proptosis. The magnetic resonance imaging (MRI) orbit demonstrated bilateral orbital masses with optic nerve encasement. A subsequent 18F-FDG PET/CT scan showed multi-organ disease with involvement of the orbits, pericardium, aorta, pararenal fascia, and appendicular bones. Metabolically active, easily accessible areas were selected for CT-guided biopsy. The biopsy showed sheets of foamy histiocytes with the expression of CD 68 and CD 163 consistent with a diagnosis of Erdheim–Chester disease. The FDG PET/CT played a pivotal role in establishing the diagnosis with the assessment of disease extent and further guided in the targeted biopsy. Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-10-06 /pmc/articles/PMC8590557/ /pubmed/34790325 http://dx.doi.org/10.1055/s-0041-1736164 Text en Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Jois, Bhargavi
Ananthasivan, Rupa
Rawat, Parameswaran R. V. Sudarshan
Rakshit, Susmita
Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
title Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
title_full Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
title_fullStr Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
title_full_unstemmed Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
title_short Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
title_sort role of (18) f-fdg pet/ct in erdheim–chester disease in the era of multimodality imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590557/
https://www.ncbi.nlm.nih.gov/pubmed/34790325
http://dx.doi.org/10.1055/s-0041-1736164
work_keys_str_mv AT joisbhargavi roleof18ffdgpetctinerdheimchesterdiseaseintheeraofmultimodalityimaging
AT ananthasivanrupa roleof18ffdgpetctinerdheimchesterdiseaseintheeraofmultimodalityimaging
AT rawatparameswaranrvsudarshan roleof18ffdgpetctinerdheimchesterdiseaseintheeraofmultimodalityimaging
AT rakshitsusmita roleof18ffdgpetctinerdheimchesterdiseaseintheeraofmultimodalityimaging